Company Filing History:
Years Active: 2015-2019
Title: Cotinica Hamel: Innovator in Amyloid Treatment
Introduction
Cotinica Hamel is a notable inventor based in Bussigny-pres-Lausanne, Switzerland. He has made significant contributions to the field of medicine, particularly in the treatment of diseases associated with amyloid and amyloid-like proteins. With a total of 2 patents, his work is paving the way for new therapeutic approaches.
Latest Patents
Hamel's latest patents focus on novel compounds that can be employed in the treatment of disorders associated with amyloid proteins, such as Alzheimer's disease. These compounds are also applicable in treating ocular diseases linked to abnormalities in the visual system. The inventions include pharmaceutical compositions that utilize these compounds for preparing medicaments aimed at treating or preventing conditions related to amyloid and amyloid-like proteins. Furthermore, a method for treating or preventing these diseases is also disclosed in his patents.
Career Highlights
Cotinica Hamel is currently associated with Ac Immune SA, a company dedicated to developing innovative therapies for neurodegenerative diseases. His work at Ac Immune has been instrumental in advancing research and development in the field of amyloid-related disorders.
Collaborations
Hamel collaborates with esteemed colleagues such as Heiko Kroth and Pascal Benderitter. Their combined expertise contributes to the innovative research and development efforts at Ac Immune.
Conclusion
Cotinica Hamel's contributions to the treatment of amyloid-related diseases highlight his role as a significant inventor in the medical field. His innovative compounds and methods are set to make a lasting impact on the treatment of conditions like Alzheimer's disease.